EPIDAREX IS A TRANSATLANTIC VENTURE CAPITAL FIRM LED BY A DIVERSE TEAM OF EARLY-STAGE INVESTORS BUILDING BREAKTHROUGH LIFE SCIENCE COMPANIES IN EMERGING HUBS
We are trusted partners to our founders and co-investors. We use our deep scientific and industry networks to create exceptional value and shared success.
Epidarex builds the extraordinary.
Recent News
RapidPulse Announces Patient Enrollment Initiated in Pivotal Ischemic Stroke Study
May 06, 2025 11:00 ET | Source: RapidPulse, Inc MIAMI, May 06, 2025 (GLOBE NEWSWIRE) — RapidPulse, Inc., a Delaware corporation headquartered in Miami, Florida
Topas claims success in early test of ‘immune tolerance’ therapy for celiac disease
by Ryan Cross on May 5th, 2025 Topas Therapeutics, a small German biotech company attempting to quell overactive immune systems, has revealed the